GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →

Pharmaceuticals

Latest articles

Image for Novo Nordisk appoints Mars CEO as board observer
Finance

Novo Nordisk appoints Mars CEO as board observer

COPENHAGEN, March 26 (Reuters) - Novo Nordisk on Thursday elected Poul Weihrauch, CEO of family-owne...

26th March, 2026

Image for Novo Nordisk cuts Wegovy price in South Africa for a second time
Finance

Novo Nordisk cuts Wegovy price in South Africa for a second time

By Nqobile Dludla JOHANNESBURG, March 25 (Reuters) - Novo Nordisk is cutting South African prices of...

25th March, 2026

Image for Analysis-TrumpRx lists many medicines at prices higher than paid in UK
Finance

Analysis-TrumpRx lists many medicines at prices higher than paid in UK

By Bhanvi Satija and Michael Erman March 18 (Reuters) - U.S. President Donald Trump pledged to make...

18th March, 2026

Image for Roche ramps up AI computing capacity with Nvidia chip expansion
Finance

Roche ramps up AI computing capacity with Nvidia chip expansion

BERLIN, March 16 (Reuters) - Swiss drugmaker Roche said on Monday it had expanded its artificial int...

16th March, 2026

Image for Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit
Finance

Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit

By Gabriel Araujo and Luciana Magalhaes SAO PAULO, March 10 (Reuters) - Brazilian drugmaker EMS is o...

10th March, 2026

Image for Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit
Finance

Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit

COPENHAGEN, March 9 (Reuters) - Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic d...

9th March, 2026

Image for Roche shares drop as oral breast cancer drug fails in trial
Finance

Roche shares drop as oral breast cancer drug fails in trial

FRANKFURT, March 9 (Reuters) - Shares in Roche dropped more than 5% on Monday as the Swiss drugmaker...

9th March, 2026

Image for GSK licenses liver disease drug to Italy's Alfasigma for up to $690 million
Finance

GSK licenses liver disease drug to Italy's Alfasigma for up to $690 million

March 9 (Reuters) - GSK said on Monday it will receive up to $690 million from Italian pharmaceutica...

9th March, 2026

Image for Galderma gives better than expected 2026 guidance, shares rise
Finance

Galderma gives better than expected 2026 guidance, shares rise

March 5 (Reuters) - Shares of Swiss skincare company Galderma opened higher on Thursday after it rep...

5th March, 2026

Image for Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion
Finance

Sino Biopharm unit licenses blood cancer drug to Sanofi for up to $1.53 billion

March 4 (Reuters) - Hong Kong-listed Sino Biopharmaceutical said on Wednesday its unit has signed an...

3rd March, 2026

Image for Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports
Finance

Hims' pharmacy partner will reintroduce GLP-1 pill pulled from market, Endpoints News reports

March 3 (Reuters) - Hims & Hers Health's pharmacy partner, Strive Pharmacy, plans to resume sales of...

3rd March, 2026

Image for Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports
Finance

Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports

BERLIN, March 3 (Reuters) - Swiss pharmaceutical company Roche is aiming for a double-digit market s...

3rd March, 2026